Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)

Harmen R. Moes; Erik Buskens; Teus van Laar

doi:10.1186/s12883-024-03743-8

Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)

Harmen R. Moes^*, Erik Buskens, Teus van Laar

^*Corresponding author for this work

Research output: Contribution to journal › Erratum

6 Downloads (Pure)

Abstract

Following publication of the original article [1], the authors reported that the reference details to Antonini et al., 2024 (the other commentary in Matters Arising) are not correct. The correct details of the reference should be “Antonini A., Chaudhuri K.R., Domingos J., Jimenez-Shahed J., Wright J., Yan C.H., Alobaidi A., Bergmann L., Onuk K., Harmer L. and Malaty I. A. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”. BMC Neurology. 2024. https://doi.org/10.1186/s12883-024-03691-3”. The original article [1] has been updated.

Original language	English
Article number	240
Number of pages	1
Journal	BMC NEUROLOGY
Volume	24
DOIs	https://doi.org/10.1186/s12883-024-03743-8
Publication status	Published - 10-Jul-2024

Access to Document

10.1186/s12883-024-03743-8Licence: CC BY

Correction- Comment on “Does the 5-2- 1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”Final publisher's version, 610 KBLicence: CC BY

Handle.net

Persistent link

Fingerprint

Dive into the research topics of 'Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)'. Together they form a unique fingerprint.

1 Comment/Letter to the editor

Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”
Moes, H. R., Buskens, E. & van Laar, T., Dec-2024, In: BMC NEUROLOGY. 24, 1, 4 p., 189.
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Open Access
File
1 Citation (Scopus)

12 Downloads (Pure)

Cite this

Moes, H. R., Buskens, E., & van Laar, T. (2024). Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2). BMC NEUROLOGY, 24, Article 240. https://doi.org/10.1186/s12883-024-03743-8

@article{9f44a077614641e080a0b4eaf7879288,

title = "Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson{\textquoteright}s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)",

abstract = "Following publication of the original article [1], the authors reported that the reference details to Antonini et al., 2024 (the other commentary in Matters Arising) are not correct. The correct details of the reference should be “Antonini A., Chaudhuri K.R., Domingos J., Jimenez-Shahed J., Wright J., Yan C.H., Alobaidi A., Bergmann L., Onuk K., Harmer L. and Malaty I. A. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson{\textquoteright}s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”. BMC Neurology. 2024. https://doi.org/10.1186/s12883-024-03691-3”. The original article [1] has been updated.",

author = "Moes, {Harmen R.} and Erik Buskens and {van Laar}, Teus",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = jul,

day = "10",

doi = "10.1186/s12883-024-03743-8",

language = "English",

volume = "24",

journal = "BMC NEUROLOGY",

issn = "1471-2377",

publisher = "BioMed Central Ltd.",

}

Moes, HR , Buskens, E & van Laar, T 2024, 'Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)', BMC NEUROLOGY, vol. 24, 240. https://doi.org/10.1186/s12883-024-03743-8

Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2). / Moes, Harmen R.; Buskens, Erik ; van Laar, Teus.
In: BMC NEUROLOGY, Vol. 24, 240, 10.07.2024.

Research output: Contribution to journal › Erratum

TY - JOUR

T1 - Correction to

T2 - Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)

AU - Moes, Harmen R.

AU - Buskens, Erik

AU - van Laar, Teus

PY - 2024/7/10

Y1 - 2024/7/10

N2 - Following publication of the original article [1], the authors reported that the reference details to Antonini et al., 2024 (the other commentary in Matters Arising) are not correct. The correct details of the reference should be “Antonini A., Chaudhuri K.R., Domingos J., Jimenez-Shahed J., Wright J., Yan C.H., Alobaidi A., Bergmann L., Onuk K., Harmer L. and Malaty I. A. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”. BMC Neurology. 2024. https://doi.org/10.1186/s12883-024-03691-3”. The original article [1] has been updated.

AB - Following publication of the original article [1], the authors reported that the reference details to Antonini et al., 2024 (the other commentary in Matters Arising) are not correct. The correct details of the reference should be “Antonini A., Chaudhuri K.R., Domingos J., Jimenez-Shahed J., Wright J., Yan C.H., Alobaidi A., Bergmann L., Onuk K., Harmer L. and Malaty I. A. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”. BMC Neurology. 2024. https://doi.org/10.1186/s12883-024-03691-3”. The original article [1] has been updated.

UR - http://www.scopus.com/inward/record.url?scp=85198028215&partnerID=8YFLogxK

U2 - 10.1186/s12883-024-03743-8

DO - 10.1186/s12883-024-03743-8

M3 - Erratum

C2 - 38987718

AN - SCOPUS:85198028215

SN - 1471-2377

VL - 24

JO - BMC NEUROLOGY

JF - BMC NEUROLOGY

M1 - 240

ER -

Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)

Abstract

Access to Document

Handle.net

Other files and links

Fingerprint

Research output

Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”

Cite this